Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
In the TRIUMPH-1 Phase 3 trial, participants on the highest dose of retatrutide lost an average of 28.3% of their body weight at 80 weeks
PMID 37154744
GLP-1 receptor agonists Including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are peptide-based drugs that have completed full FDA review and carry approved indications for type 2 diabetes and obesity
The spray format ships pre-formulated, removing the reconstitution step required for lyophilized vials
Stuart Phillips is a professor of Kinesiology and the Tier 1 Canada Research Chair in Skeletal Muscle Health
.png)
US$ 24.22
.webp?width=900&height=1201&name=Semaglutide%20Image%202_900x1200%20(without%20phone).webp)
US$ 23.62
US$ 28.73
US$ 25.01
